Severe relapses under fingolimod treatment prescribed after natalizumab

Neurology. 2012 Nov 6;79(19):2004-5. doi: 10.1212/WNL.0b013e3182735c7a. Epub 2012 Oct 3.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Female
  • Fingolimod Hydrochloride
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • JC Virus / immunology
  • JC Virus / pathogenicity
  • Leukoencephalopathy, Progressive Multifocal / chemically induced*
  • Leukoencephalopathy, Progressive Multifocal / drug therapy*
  • Magnetic Resonance Imaging
  • Natalizumab
  • Propylene Glycols / therapeutic use*
  • Recurrence
  • Sphingosine / analogs & derivatives*
  • Sphingosine / therapeutic use

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunosuppressive Agents
  • Natalizumab
  • Propylene Glycols
  • Fingolimod Hydrochloride
  • Sphingosine